T

Trajan Group Holdings Ltd
ASX:TRJ

Watchlist Manager
Trajan Group Holdings Ltd
ASX:TRJ
Watchlist
Price: 0.975 AUD -1.02% Market Closed
Market Cap: 148.5m AUD
Have any thoughts about
Trajan Group Holdings Ltd?
Write Note

Trajan Group Holdings Ltd
Accumulated Depreciation

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Trajan Group Holdings Ltd
Accumulated Depreciation Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accumulated Depreciation CAGR 3Y CAGR 5Y CAGR 10Y
T
Trajan Group Holdings Ltd
ASX:TRJ
Accumulated Depreciation
-AU$22.8m
CAGR 3-Years
-31%
CAGR 5-Years
-39%
CAGR 10-Years
N/A
Anteotech Ltd
ASX:ADO
Accumulated Depreciation
-AU$4.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Proteomics International Laboratories Ltd
ASX:PIQ
Accumulated Depreciation
-AU$2.7m
CAGR 3-Years
-26%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cryosite Ltd
ASX:CTE
Accumulated Depreciation
-AU$3.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Genetic Signatures Ltd
ASX:GSS
Accumulated Depreciation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
E
EZZ Life Science Holdings Ltd
ASX:EZZ
Accumulated Depreciation
-AU$525.9k
CAGR 3-Years
-63%
CAGR 5-Years
-174%
CAGR 10-Years
N/A
No Stocks Found

Trajan Group Holdings Ltd
Glance View

Market Cap
148.4m AUD
Industry
Life Sciences Tools & Services

Trajan Group Holdings Ltd. engages in the designing, manufacturing and supply of products and solutions that enhance scientific measurement. The firm is developing and manufacturing analytical science instruments, devices and solutions used in the analysis of biological, food and environmental samples. The firm is focused on serving life science, biopharmaceutical, and analytical companies in the United States, Australia, Europe, and Asia. The firm is operating in two segments, which includes Analytical Products and Life Science Solutions. Its Analytical Products include Metal syringes, Gas tight syringes, eVol, liquid extraction (uLLE), Electrokinetic extraction (EkE), Ferrules, Microfluidics, Emitter tips, Septa and caps and Porous polymer monoliths. Its Life Science Solutions include Dispensing syringes, Microscope slides, Coverslips, Slide and cassette storage, Liquid powder dispensing, Infusion automation, hemaPEN, Microbiopsy and Hummingbird. The company also offers micro-biopsy device for skin sampling, including Mitra device.

TRJ Intrinsic Value
2.499 AUD
Undervaluation 61%
Intrinsic Value
Price
T

See Also

What is Trajan Group Holdings Ltd's Accumulated Depreciation?
Accumulated Depreciation
-22.8m AUD

Based on the financial report for Jun 30, 2024, Trajan Group Holdings Ltd's Accumulated Depreciation amounts to -22.8m AUD.

What is Trajan Group Holdings Ltd's Accumulated Depreciation growth rate?
Accumulated Depreciation CAGR 5Y
-39%

Over the last year, the Accumulated Depreciation growth was -29%. The average annual Accumulated Depreciation growth rates for Trajan Group Holdings Ltd have been -31% over the past three years , -39% over the past five years .

Back to Top